Roche 3Q Sales Grew; Raises Outlook
20 October 2021 - 4:51PM
Dow Jones News
By Cecilia Butini
Roche Holding AG said Wednesday that sales for the third quarter
rose on year and raised its outlook for the full year.
The Swiss pharma major posted sales of 15.97 billion Swiss
francs ($17.31 billion) for the third quarter, up from CHF14.70
billion in the same period in 2020.
In the first nine months of the year, sales were CHF46.68
billion from CHF43.98 billion the year prior, Roche said.
Sales in the company's pharmaceutical division grew 5% in the
third quarter and are now in line with the previous year for the
first nine months, Roche said.
The company's diagnostics division had sales growth of 18% in
the third quarter and 39% in the first nine months due to high
demand for Covid-19 tests, a recovery in the base business, and the
newly launched diagnostics platforms, according to Roche.
The company raised its outlook for the year. It now expects
sales to grow in the mid-single digit range at constant exchange
rates. It had previously expected sales to grow in the low to mid
single digit range.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
October 20, 2021 01:36 ET (05:36 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From Apr 2024 to May 2024
Roche (QX) (USOTC:RHHBY)
Historical Stock Chart
From May 2023 to May 2024